Expertise in
39
conditions

Dr. Asim R. Pati

Hematology
SMc-Center For Hematology/Oncology-Spartanburg
380 Serpentine Dr Ste 200, 
Spartanburg, SC 
Accepting New Patients
Expertise in
39
conditions
SMc-Center For Hematology/Oncology-Spartanburg
380 Serpentine Dr Ste 200, 
Spartanburg, SC 

Overview

Asim Pati is a Hematologist practicing medicine in Spartanburg, South Carolina.

Dr. Pati is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Anemia, Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 4 clinical trials. Dr. Pati is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in SC

Hospital Affiliations

Spartanburg Medical Center
Pelham Medical Center

Languages Spoken

English
Bengali

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

SMc-Center For Hematology/Oncology-Spartanburg
380 Serpentine Dr Ste 200, Spartanburg, SC 29303

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL)
A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL)
Enrollment Status: Active_not_recruiting
Publish Date: August 06, 2026
Intervention Type: Other
Study Phase: Not Applicable
A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Drug, Biological, Procedure, Other, Radiation
Study Drugs: Brentuximab, Dacarbazine, Doxorubicin, Filgrastim, Nivolumab, Pegfilgrastim, Vinblastine
Study Phase: Phase 3
Open Label, Phase 2, Single-Arm Study of Selinexor, Daratumumab, Carfilzomib and Dexamethasone for High-Risk, Relapsed and Relapsed/Refractory Multiple Myeloma Patients Who Have Received 1 - 3 Prior Lines of Therapy
Open Label, Phase 2, Single-Arm Study of Selinexor, Daratumumab, Carfilzomib and Dexamethasone for High-Risk, Relapsed and Relapsed/Refractory Multiple Myeloma Patients Who Have Received 1 - 3 Prior Lines of Therapy
Enrollment Status: Active_not_recruiting
Publish Date: September 26, 2024
Intervention Type: Other, Biological, Drug
Study Drugs: Carfilzomib, Daratumumab, Dexamethasone, Selinexor
Study Phase: Phase 2
Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL)
Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL)
Enrollment Status: Completed
Publish Date: December 01, 2021
Intervention Type: Drug, Radiation
Study Drugs: Doxorubicin, Bleomycin, Vinblastine, Dacarbazine, Etoposide, Cyclophosphamide, Vincristine, Procarbazine, Prednisone
Study Phase: Phase 2
View 3 Less Clinical Trials

1 Total Publications

Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.
Journal: JCO oncology practice
Published: October 30, 2020
Similar Doctors
Expertise in
46
conditions
Dr. Ki Y. Chung
Hematology | Hematology Oncology | Oncology
Expertise in
46
conditions
Dr. Ki Y. Chung
Hematology | Hematology Oncology | Oncology
Referral required
Before you request

Prisma Health Cancer Institute Spartanburg

2400 Boiling Springs Rd, 
Boiling Springs, SC 
 (2.2 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ki Chung is a Hematologist and a Hematologist Oncology provider practicing medicine in Boiling Springs, South Carolina. Dr. Chung is highly rated in 46 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lung Cancer, and Familial Pancreatic Cancer. Dr. Chung is board certified in American Board Of Internal Medicine. Dr. Chung is currently accepting new patients.

Expertise in
67
conditions
Dr. Michael Humeniuk
Hematology | Oncology
Expertise in
67
conditions
Dr. Michael Humeniuk
Hematology | Oncology
Referral may be required

Smc Center For Hematology Oncology Spartanburg

380 Serpentine Dr, 
Spartanburg, SC 
 (2.4 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Humeniuk is a Hematologist and an Oncologist practicing medicine in Spartanburg, South Carolina. Dr. Humeniuk is highly rated in 67 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Prostate Cancer, Pleuropulmonary Blastoma, Urothelial Cancer, and Endoscopy. Dr. Humeniuk is currently accepting new patients.

Expertise in
76
conditions
Dr. Britt H. Bolemon
Hematology | Hematology Oncology | Oncology
Expertise in
76
conditions
Dr. Britt H. Bolemon
Hematology | Hematology Oncology | Oncology
Referral required
Before you request

Prisma Health Cancer Institute – Eastside

65 International Drive, 
Greenville, SC 
 (22.8 miles away)
864-987-7000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Britt Bolemon is a Hematologist and a Hematologist Oncology provider practicing medicine in Greenville, South Carolina. Dr. Bolemon is highly rated in 76 conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Lung Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Bolemon is board certified in American Board Of Internal Medicine. Dr. Bolemon is currently accepting new patients.

Frequently Asked Questions about Dr. Asim R. Pati

How do I make an appointment with Dr. Asim R. Pati?

You can book an appointment with Dr. Asim R. Pati by calling their office at 864-560-7050. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Asim R. Pati a top-rated expert for Thrombocytopenia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Asim R. Pati is classified as an Distinguished expert for Thrombocytopenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Asim R. Pati specialize in?

While Dr. Asim R. Pati is a Hematology, they have specific expertise in Thrombocytopenia, Anemia, and Richter Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Asim R. Pati participate in research or clinical trials?

Yes. Dr. Asim R. Pati has published 1 articles and abstracts on conditions like Thrombocytopenia. You can view a list of Dr. Asim R. Pati's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Asim R. Pati accept my insurance?

Dr. Asim R. Pati accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 864-560-7050 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pati's expertise for a condition
ConditionClose
    View All 33 Advanced Conditions
    View All 47 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile